nephropathy
美 [nə'frɒpəθɪ]英 [nə'frɒpəθɪ]
- n.〔医〕肾病
- 网络肾病变；肾脏病变；肾病科
复数：nephropathies
nephropathynephropathy
肾病
英语—医学 ... nephro-[ 肾] ▲ nephropathy[ 肾病] ▲ nephrosclerosis[ 肾硬变] · ...
肾病变
2. 肾病变(Nephropathy) 23 （1）临床上收集病患二十四小时尿液检体以早期侦测肾病变。 （2）预防及延缓肾病变发生之措施 …
肾脏病变
排除：肾脏病变（nephropathy） NOS 没有提及形态学上的损害（N28.9） 肾脏疾病（renal disease ） NOS 没有提及形态学 …
肾病科
fanhua001.com：SEO网站审查 - Chlooe.com ... 肝病科/ hepatopathy/ 肾病科/ nephropathy/ 泌尿科/ urology/ ...
糖尿病性肾病
血管的变性：发生在肾脏就会造成糖尿病性肾病(nephropathy)，发生在眼睛，就会造成糖尿病性视网膜病变(retinopathy)和失明 …
糖尿病肾脏病变
糖尿病肾脏病变(nephropathy)会导致蛋白尿，高血压，肾丝球滤过
肾脏伤害
...越严重，血管会开始渗露，可能造成永久性的神经伤害、肾脏伤害（nephropathy）、心脏病及视网膜病变（retinopathy）， …
1
Furthermore, estimates of risk for progression could have been biased by patients who died before their nephropathy might have progressed.
此外，对进展的风险估计可能有偏差，因为有些病人去世时肾病可能已经进展。
2
At present, GSH has been used in the treatment of diabetic neuropathy, diabetic nephropathy, diabetes fatty liver.
目前，GSH已用于糖尿病神经病变、糖尿病肾病、糖尿病脂肪肝等并发症的治疗。
3
Contrast-induced nephropathy has no specific treatment and identifying high-risk patients is the key to reduce this disease.
造影剂肾病无特殊治疗方法，识别高风险患者是减少造影剂肾病的关键。
4
It was the important pathologic basis of diabetic nephropathy that extracellular matrix gradually accumulation.
细胞外基质进行性积聚是导致糖尿病肾病发生、发展的重要病理基础。
5
It was also demonstrated that irbesartan had the renal protective effects and could reduce the progression of diabetic nephropathy.
厄贝沙坦另有重要的肾脏保护作用，可延迟糖尿病肾病的发生。
6
In this paper, traditional Chinese medicine over the last decade the treatment of diabetic nephropathy simple review and prospects.
本文就近十年来中医对糖尿病肾病的治疗进行简单的回顾和展望。
7
Old patients of cities take up a great proportion in heart disease, microcycle system dease and diabetes, nephropathy of internal secretion.
在心脏病、微循环系统疾病，以及内分泌系统糖尿病肾病中，以城市老年患者占据绝对比重。
8
Conclusions: Amyloid nephropathy was a kind of infrequent disease, and doctors should heighten cognizance of it.
结论：淀粉样变肾病系少见病，应注意对该病的认识。
9
Severe proteinuria and hematuria were also noted and a renal biopsy revealed uric acid nephropathy superimposed on lupus nephritis.
肾臓切片检查结果显示这位病人罹患急性酸性肾病变合并狼疮性肾炎。
10
Adjustments in immunosuppression therapy should be considered for patients who develop BK virus-associated nephropathy.
对于发生BK病毒肾病的患者，应考虑调整免疫抑制治疗。
11
Diabetic nephropathy is one of the most serious complications of diabetes mellitus and it seriously endangers people's health.
糖尿病肾病是糖尿病最为严重的并发症之一，严重危害人类的健康。
12
Prof. Ritz: Microalbuminuria is of course the predictor of the first stage of progressive diabetic nephropathy.
EberhardRitz教授：当然，MAU是进展性糖尿病肾病第一阶段的预测因子。
13
Conclusion The diabetic nephropathy patients have imbalance of plasma plasminogen activator and its inhibitor system.
结论：糖尿病肾病患者存在血浆纤溶酶原激活物及其抑制物系统失衡。
14
Diabetic nephropathy is the leading cause of chronic renal disease and a major cause of cardiovascular mortality.
糖尿病肾病是慢性肾脏疾病以及因心血管死亡的主要原因。
15
Objective: To evaluate the efficacy and safety of the pancreatic kininogenase tablets in treating early stage diabetic nephropathy.
目的：评价胰激肽原酶片治疗早期糖尿病肾病患者的疗效和安全性。
16
abstract: Objective To investigate the plasminogen activator inhibitor changes in patients with diabetic nephropathy.
目的：探讨糖尿病肾病患者血浆纤溶酶原激活物抑制物的变化。
17
Objective To investigate the nursing experience of early diabetic nephropathy by treating with aldosterone receptor antagonist.
目的探讨醛目酮受体拮抗剂治疗早期糖尿病肾病的临床护理体会。
18
Conclusion Glycyrrhizin has some therapeutical but no preventive effect to experimental obstructive nephropathy in rats.
结论甘草酸对大鼠梗阻性肾病具有一定的治疗作用，但无预防作用。
19
Results Vesicoureteral reflux can be seen from CT in all patients suffered from reflux nephropathy in different degree.
结果：返流性肾病在CT表现上都有不同程度的膀胱输尿管返流。
20
Uric acid nephropathy and lupus nephritis are often the cause of renal failure.
尿酸性肾病变和狼疮性肾炎常常是肾衰竭的原因。
21
The natural course of idiopathic membranous nephropathy is characterized by a high incidence of spontaneous remissions.
自然的过程中特发性膜性肾病的特点是发病率高自发缓解。
22
Albuminuria is the best available surrogate parameter in the treatment of diabetic nephropathy.
蛋白尿是糖尿病肾病治疗最好用的代表参数。
23
Research on the mechanism of diabetic nephropathy was initially focused on the mesangial matrix and glomerular basement membrane.
有关糖尿病肾病发病机制的研究，人们早先关注的是肾脏系膜基质堆积和肾小球基底膜增厚。
24
Objective To observe clinical therapeutic effect of combination therapy with okra capsule and valsartan for diabetic nephropathy.
目的观察黄葵胶囊联合缬沙坦治疗糖尿病肾病临床疗效。
25
Objective To investigate the protective role of glycyrrhizin on experimental obstructive nephropathy in rats.
目的研究甘草酸对实验性梗阻性肾病大鼠是否具有保护作用。
26
Therefore, keep balance of levels of CGRP and ET in plasma may be benefit for prevention and cure of diabetic nephropathy.
在糖尿病早期，维持CGRP和ET的动态平衡有利于防治糖尿病肾病的发生、发展。
27
abstract: Objective: To explore the clinical value of serum toal bilirubin(tbil) and superoxide dismutase(sod) in diabetic nephropathy.
目的：探讨血清总胆红素水平与超氧化物歧化酶活性在糖尿病肾病中的临床价值。
28
Results The quantity and volume of the blood platelet in diabetic nephropathy may change evidently and take effect in DN.
结论DN时血小板的数量、体积均发生明显改变，在DN的发生、发展中起一定作用。
29
abstract: Objective: To evaluate the clinical effects of tripterygium for diabetic nephropathy.
目的：探讨雷公藤多苷片用于治疗糖尿病肾病的临床效果。
30
Study on Correlation between Therapeutic Effect and ACE Gene in Diabetic Nephropathy Treated by "Minor Four and Five Decoction"
“小四五汤”治疗糖尿病肾病疗效与ACE基因相关性研究